IHI

iShares US Medical Devices ETF

Investing.com -- UBS continues to view the medical devices sector as a high-quality, defensive investment theme, supported by long-term demographic shifts and rising global demand.

Investing.com -- Citi analysts revised their MedTech coverage following a volatile first quarter, with several rating changes and adjustments to target prices.

While Medtronic has underperformed relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Boston Scientific has outpaced the broader market over the past year and analysts are highly upbeat about its future prospects.

Investing.com -- Bank of America analysts say GE HealthCare (NASDAQ:GEHC) should benefit from signs of softening in the U.S.-China trade war, arguing that the worst of the tariff-related pressure may already be priced into the stock.

Investing.com -- HSBC has reshuffled its ratings across the MedTech and Life Sciences sector, upgrading Siemens Healthineers AG (ETR:SHLG) and Sonova (SIX:SOON) to Buy while cutting Align Technology (NASDAQ:ALGN), Eurofins Scientific SE (EPA:EUFI), IQVIA, and Smith&Nephew (LON:SN) to Hold.

The device, known as the Layer 7 Cortical Interface, is a thin, flexible microelectrode array designed to record and stimulate neural activity without penetrating brain tissue.

Due to Teleflex’s underperformance relative to its industry peers over the past six months, Wall Street analysts remain cautious about the stock’s prospects.